In the present study, we found that EZH2 was significantly overexpressed in triple- negative breast carcinoma and was associated with high tumor cell proliferation, whereas low grade ER-positive breast carcinoma such as tubular carcinoma and mucinous carcinoma showed low EZH2 expression levels. This evidence concerns the gene EZH2 and neoplasm.